Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2008
12/11/2008US20080306110 Alkylnitrile Quinolines as Nk-3 Receptor Ligands
12/11/2008US20080306106 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
12/11/2008US20080306104 Tamper-resistant oral opioid agonist formulations
12/11/2008US20080306103 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
12/11/2008US20080306092 Pyrazolo [1,5-Alpha] Pyrimidinyl Derivatives Useful as Corticotropin-Releasing Factor (Crf) Receptor Antagonists
12/11/2008US20080306089 Prolinamide-tetrazole derivatives as nk3 receptor antagonists
12/11/2008US20080306088 7-chloro-5-(5-piperazin-1-ylmethyl-[1,2,4]oxadiazol-3-yl)-2-(4-trifluoromethoxybenzyl)-2,3-dihydroisoindol-1-one, for the treatment of nervous system disorders and psychological disorders
12/11/2008US20080306087 1-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-4-(2-nitro-phenylmethanesulfonyl)-piperazine; acylation or sulfonamidation of the piperazine ring; psychological disorders, Parkinson's, Alzheimer's, Huntington's Diseases; antidepressants, entiepileptics
12/11/2008US20080306086 for the treatment of depression, pain, psychosis, Parkinson's disease, schizophrenia, anxiety and attention deficit hyperactivity disorder (ADHD); 2-{4-[(2S,4S)-1-benzyl-4-(2,4-difluoro-benzylamino)-pyrrolidine-2-carbonyl]-piperazin-1-yl}-benzonitrile
12/11/2008US20080306085 Non-imidazole aryloxyalkylamines
12/11/2008US20080306081 Combinations of Nicotinic Acetylcholine Alpha 7 Receptor Antagonists
12/11/2008US20080306078 3,9-Diazabicyclo [3.3.1] Nonane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
12/11/2008US20080306077 Oxadiazole Derivatives and Their Use as Metabotropic Glutamate Receptor Potentiators 842
12/11/2008US20080306074 Compositions Comprising Addl Receptors, Related Compositions, and Related Methods
12/11/2008US20080306071 Substituted piperidine compounds and methods of their use
12/11/2008US20080306068 Suppression cytokines, tumor necrosis factor
12/11/2008US20080306066 Non-imidazole heterocyclic compounds
12/11/2008US20080306065 Metalloproteinase Inhibitors
12/11/2008US20080306060 Fused Thiazole Derivatives as Kinase Inhibitors
12/11/2008US20080306055 Heterocyclic Mchr1 Antagonists And Their Use In Therapy
12/11/2008US20080306049 Therapeutic pyrazoloquinoline derivatives
12/11/2008US20080306048 Therapeutic pyrazoloquinoline urea derivatives
12/11/2008US20080306046 Pyridyl Non-Aromatic Nitrogen-Containing Heterocyclic-1-Carboxylate Derivative
12/11/2008US20080306043 Sabcomeline Alone or Combined with a Mood Stabilising or Antimanic Agent to Treat Bipolar Disorders
12/11/2008US20080306036 Triphenylethylene Compounds Useful as Selective Estrogen Modulators
12/11/2008US20080306025 N-(phosphonoalkyl)-amino acids, derivatives thereof and compositions and methods of use
12/11/2008US20080306019 Dopamine Receptor Agonists in the Treatment and Prevention of Hiv-Induced Dementia
12/11/2008US20080306007 Agents for prophylaxis or treatment of neurological related diseases and conditions
12/11/2008US20080305171 Pyrrolopyrazine, formulations, methods of manufacture, and methods of use there
12/11/2008US20080305167 Tamper-resistant oral opioid agonist formulations
12/11/2008US20080305164 Crystalline composition containing escitalopram
12/11/2008US20080305148 Treatment of spinal injuries using human umbilical mesenchymal stem cells
12/11/2008US20080305086 Human late stage motor neuron progenitor cells and methods of making and using same
12/11/2008US20080305077 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
12/11/2008CA2727100A1 Treatment of neurofibromatosis with radicicol and its derivatives
12/11/2008CA2690856A1 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842
12/11/2008CA2690292A1 Prolinamide-tetrazole derivatives as nk3 receptor antagonists
12/11/2008CA2690151A1 Enteric coated, soluble creatine and polyethylene glycol composition for enhanced skeletal uptake of oral creatine
12/11/2008CA2690091A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
12/11/2008CA2689909A1 Long-acting polymeric prodrugs of exendin
12/11/2008CA2689692A1 New disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission
12/11/2008CA2689560A1 Prolinamide derivatives as nk3 antagonists
12/11/2008CA2688493A1 Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
12/11/2008CA2688463A1 Process for the preparation of rizatriptan
12/11/2008CA2687866A1 Anti-notch1 nrr antibodies and methods using same
12/11/2008CA2687414A1 Humanized antibodies to a.beta. (20-42) globulomer and uses thereof
12/10/2008EP2000479A1 Genetic Sequences and Proteins Related to Alzheimer's Disease, and Uses Therefor
12/10/2008EP2000469A2 Acylaminopiperidine compound
12/10/2008EP2000462A2 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
12/10/2008EP2000144A1 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono-and disaccharide-based compounds
12/10/2008EP2000141A1 Methods for preparing crystalline quetiapine hemifumarate
12/10/2008EP2000136A2 Compositions and methods for the treatment of inflammatory diseases using topoisomerase inhibitors
12/10/2008EP2000134A1 Use of a substance for the improvement of pns lesions
12/10/2008EP1999150A1 New protein isoforms and uses thereof
12/10/2008EP1999135A2 Kinase inhibitors
12/10/2008EP1999121A1 Novel tetralins as 5-ht6 modulators
12/10/2008EP1999120A1 Benzothiazoles having histamine h3 receptor activity
12/10/2008EP1999100A1 Process for preparing memantine hydrochloride substantially free of impurities
12/10/2008EP1998791A1 Suppression and treatment of neuropathic pain
12/10/2008EP1998781A2 Treatment of pain
12/10/2008EP1998780A2 New therapeutic combinations for the treatment or prevention of psychotic disorders
12/10/2008EP1998778A1 Use of (s)-roscovitine for manufacturing a medicine
12/10/2008EP1998777A1 Methods of inhibiting btk and syk protein kinases
12/10/2008EP1998775A2 Bis1,2,3,4-tetrahydroisoquinoline derivatives and their uses as pharmaceuticals
12/10/2008EP1998774A1 Tetrahydroisoquinoline derivatives to enhance memory function
12/10/2008EP1998773A2 New therapeutic combinations for the treatment of depression
12/10/2008EP1998771A2 Use of tetrahydropyridines in the treatment of central nervous system disorders
12/10/2008EP1998764A2 Methods for treating cognitive and other disorders
12/10/2008EP1753757B1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/10/2008EP1706113B1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride
12/10/2008EP1648897B1 N- [3-(3-substituted-pyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-sulfonamides, and compositions, and methods related thereto
12/10/2008EP1539765B1 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
12/10/2008EP1519738B1 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
12/10/2008EP1511730B1 Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
12/10/2008EP1475382B1 Compounds as semaphorin inhibitors
12/10/2008EP1404317B1 5-halo-tryptamine derivatives used as ligands of the 5-ht 6? and/or 5-ht 7? serotonin receptors
12/10/2008EP1386613B1 Topical effervescent composition
12/10/2008EP1379222B1 Orodispersible effervescent tablets
12/10/2008EP1220915B1 Splice variant of head trauma induced cytoplasmatic calcium binding protein
12/10/2008EP1094816B1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/10/2008CN101321761A Tricyclic amide derivatives useful for treating obesity
12/10/2008CN101321760A Pyrazolopyrimidines as protein kinase inhibitors
12/10/2008CN101321754A New compounds II
12/10/2008CN101321753A Novel imidazo [4,5 -b] pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
12/10/2008CN101321752A 3-amino-2-arylpropyl azaindoles and uses thereof
12/10/2008CN101321738A Spirocyclic derivatives
12/10/2008CN101321736A Compounds which have activity at m1 receptor and their uses in medicine
12/10/2008CN101321733A Quinolone M1 receptor positive allosteric modulators
12/10/2008CN101321730A Cyclopropyl amines as modulators of the histamine H3 receptor
12/10/2008CN101321531A Use of pyrimidine derivatives in the manufacture of a medicament for prevention and/or treatment of alzheimer's disease
12/10/2008CN101321526A Combination of rosiglitazone and donepezil for improvement of cognitive function
12/10/2008CN101321524A Novel uses for estrogen beta agonists
12/10/2008CN101321523A Use of a CB1 antagonist for treating side effects and negative symptoms of schizophrenia
12/10/2008CN101321515A Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer
12/10/2008CN101318985A Preparation method for ursolic acid, produced products and application thereof
12/10/2008CN101318962A Fused heterocyclic compounds
12/10/2008CN101318961A Fused heterocyclic compounds
12/10/2008CN101318952A Sigma Acceptor activator compound and uses thereof
12/10/2008CN101318943A Substituted diethylenediamine compounds, preparation method, uses and medicament composition containing the compounds
12/10/2008CN101318937A Alkaloid compounds, preparation method and application thereof
1 ... 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 ... 1833